柴胡疏肝散加減治療肝郁型不寐的臨床觀察

打開文本圖片集

【摘要】目的：分析肝郁型不寐患者實施柴胡疏肝散加減治療的價值。方法：以60例肝郁型不寐患者為樣本，樣本在2022年1月—2023年12月入選，按照數(shù)字法分組，即對照組和研究組，均有30例，對照組行艾司唑侖治療，研究組在對照組基礎(chǔ)上聯(lián)合柴胡疏肝散加減治療，比較兩組睡眠質(zhì)量、癥狀積分以及有效率。結(jié)果：治療前，研究組和對照組睡眠質(zhì)量評分無差異，P>0.05；治療后，兩組睡眠質(zhì)量評分均低于治療前，且研究組睡眠質(zhì)量評分低于對照組，P0.05；治療后，兩組癥狀積分均下降，且研究組癥狀積分低于對照組，P

【關(guān)鍵詞】肝郁型不寐；有效率；癥狀積分；柴胡疏肝散

Clinical Observation of Chaihu Shugan San modified treatment for insomnia of liver stagnation type

LI Jing

Xinjiekou Community Health Service Center， Xicheng District， Beijing City， Beijing 100035， China

【Abstract】Objective：To analyze the value of implementing modified Chaihu Shugan San in the treatment of insomnia patients with liver depression type.Methods：A sample of 60 patients with liver depression type insomnia were selected from January 2022 to December 2023，and they were divided into two groups using the numerical method，namely the control group and the study group，with 30 cases in each group.The control group received treatment with estazolam，while the study group received treatment with modified Chaihu Shugan San on the basis of the control group.The sleep quality，symptom scores，and effective rates of the two groups were compared.Results：There was no significant difference in sleep quality scores between the study group and the control group before treatment，P>0.05；After treatment，the sleep quality scores of both groups were lower than before treatment，and the sleep quality scores of the study group were lower than those of the control group，P0.05；After treatment，the symptom scores of both groups decreased，and the symptom scores of the study group were lower than those of the control group，P

【Key Words】Liver depression type insomnia； Efficient； Symptom score； Chaihu Shugan San

不寐指的是經(jīng)常無法得到正常睡眠，其病機為臟腑失調(diào)、陰陽失調(diào)、氣血失和等，表現(xiàn)為入睡困難、醒后無法再次入睡等。（剩余3964字）